XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Restricted Stock Activity
Restricted stock activity for the year ended December 31, 2022 and the nine months ended September 30, 2023 was as follows:
RSAWeighted Average Grant PricePRSUWeighted Average Grant PriceRSUWeighted Average Grant PriceTotalWeighted Average Grant Price
Nonvested balance as of December 31, 2021141,617 $23.06 63,120 $28.20 5,052 $23.56 209,789 $24.62 
Granted (1)
62,560 34.04 37,335 24.71 3,115 27.95 103,010 30.47 
Vested(62,353)23.21 (43,020)18.91 (2,062)23.20 (107,435)21.49 
Forfeited(8,507)26.15 — — — — (8,507)26.15 
Nonvested balance as of December 31, 2022133,317 27.95 57,435 32.89 6,105 25.92 196,857 29.32 
Granted (1)
— — 34,840 35.79 52,765 34.43 87,605 34.97 
Vested(55,500)27.01 (36,120)31.32 (3,253)26.07 (94,873)28.61 
Forfeited(3,340)29.00 — — (180)36.42 (3,520)29.37 
Nonvested balance as of September 30, 202374,477 $28.60 56,155 $35.70 55,437 $33.98 186,069 $32.34 
Unrecognized compensation cost (in thousands)$1,509 $1,091 $1,510 $4,110 
Weighted average remaining recognition period (in years)1.971.772.902.26
(1)The number of restricted shares/units shown includes the shares that would be granted if the target level of performance is achieved related to the performance based restricted stock units. The number of shares actually issued may vary. During the nine months ended September 30, 2023, an additional 18,060 were issued related to actual performance results of previously granted awards.
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Share-based compensation expense related to restricted stock and ESPP included in the unaudited Consolidated Statements of Income was as follows:
For the Three Months Ended September 30,For the Nine Months Ended September 30,
2023202220232022
(In Thousands)
Share-based compensation expense$643 $651 $2,349 $1,905